, and -L-5-methyl-2-deoxycytidine (EC 50 , 0.9 M). The inhibition of the presumed target, the HBV DNA polymerase, by the triphosphates of some of the -L-cytidine derivatives was also assessed. In accordance with the cell culture data, -L-Hyd4C triphosphate was the most active inhibitor, with a 50% inhibitory concentration of 0.21 M. The cytotoxicities of some of the 4-NHOH-modified -L-nucleosides were dramatically lower than those of the corresponding cytidine analogues with the unmodified 4-NH 2 group. The 50% cytotoxic concentrations for -L-Hyd4C in HepG2 and HL-60 cells were 2,500 M and 3,500 M, respectively. In summary, our results demonstrate that at least -L-Hyd4C can be recommended as a highly efficient and extremely selective inhibitor of HBV replication for further investigations.Complete and sustained suppression of viral replication remains the most important goal in the treatment of patients with chronic hepatitis B virus (HBV) infection. Nucleoside and nucleotide analogues have greatly improved the disease outcome for these patients and have also prevented hepatic decompensation or the development of hepatocellular carcinoma. While -L-2Ј,3Ј-dideoxy-3Ј-thiacytidine (3TC; lamivudine) has been approved for the treatment of HBV infections, a series of further -Lnucleosides are under clinical investigation as inhibitors of hepadnavirus infections. These include -L-2Ј,3Ј-dideoxy-3Ј-The most important advantage associated with some, but not all, of these -L-nucleosides seems to be a much higher selectivity for the viral target than for the cellular targets, resulting in reduced cytotoxicity. This quality of -L-nucleosides stimulated the search for new -L-nucleosides but also the synthesis of enantiomeric isomers of effective -D-nucleosides (7).Some of the unmodified pyrimidine and purine -L-nucleosides were synthesized for the first time more than 35 years ago (12, 28, 34) but were considered to be metabolized very poorly in mice (14). A systematic biochemical investigation of the -L-enantiomers was initiated later and demonstrated the antihuman immunodeficiency virus (HIV) activity of -L-2Ј,3Ј-dideoxycytidine (-L-ddC) in a cellular system (18). In addition, it was shown that -L-dT might be phosphorylated by herpes simplex virus type 1 (HSV-1) thymidine kinase and further, by cellular enzymes, to -L-dTTP (35).As a consequence, the effects of -L-dTTP on various cellular DNA polymerases, TdT, the Klenow fragment of Escherichia coli DNA polymerase I, and viral DNA polymerases such as HSV-1 DNA polymerase and HIV reverse transcriptase were investigated (6,32,38). We showed that -L-TTP does not influence the activity of any of the cellular DNA polymerases (␣, , ␥, ␦, or ε) or of HIV reverse transcriptase, but we demonstrated for the first time a strong inhibition of human and duck HBV DNA polymerases by -L-dTTP (concentrations resulting in 50% inhibition of HBV DNA polymerase activity [IC 50 ], 0.46 M and 1.0 M, respectively) (37). Investigations on the cellular level and in vivo experim...